Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2410206662', 'doi': 'https://doi.org/10.1097/01.jcp.0000150235.37737.02', 'title': 'Cannabis-Induced Extrapyramidalism in a Patient on Neuroleptic Treatment', 'display_name': 'Cannabis-Induced Extrapyramidalism in a Patient on Neuroleptic Treatment', 'publication_year': 2005, 'publication_date': '2005-02-01', 'ids': {'openalex': 'https://openalex.org/W2410206662', 'doi': 'https://doi.org/10.1097/01.jcp.0000150235.37737.02', 'mag': '2410206662', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15643106'}, 'language': 'es', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/01.jcp.0000150235.37737.02', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S76849566', 'display_name': 'Journal of Clinical Psychopharmacology', 'issn_l': '0271-0749', 'issn': ['0271-0749', '1533-712X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5001316950', 'display_name': 'Carlos Rejón Altable', 'orcid': 'https://orcid.org/0000-0003-4076-0066'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Carlos Rejón Altable', 'raw_affiliation_strings': ['Centres Assistencials Dr. Emili Mira i Lopez, Santa Coloma de Gramanet, Barcelona, Spain [email\xa0protected]'], 'affiliations': [{'raw_affiliation_string': 'Centres Assistencials Dr. Emili Mira i Lopez, Santa Coloma de Gramanet, Barcelona, Spain [email\xa0protected]', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042713793', 'display_name': 'Amanda Rodríguez‐Urrutia', 'orcid': 'https://orcid.org/0000-0001-6882-205X'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Amanda Rodríguez Urrutia', 'raw_affiliation_strings': ['Centres Assistencials Dr. Emili Mira i Lopez, Santa Coloma de Gramanet, Barcelona, Spain [email\xa0protected]'], 'affiliations': [{'raw_affiliation_string': 'Centres Assistencials Dr. Emili Mira i Lopez, Santa Coloma de Gramanet, Barcelona, Spain [email\xa0protected]', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5059590880', 'display_name': 'Ma. Isabel Carrión Martínez', 'orcid': None}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Ma. Isabel Carrión Martínez', 'raw_affiliation_strings': ['Centres Assistencials Dr. Emili Mira i Lopez, Santa Coloma de Gramanet, Barcelona, Spain [email\xa0protected]'], 'affiliations': [{'raw_affiliation_string': 'Centres Assistencials Dr. Emili Mira i Lopez, Santa Coloma de Gramanet, Barcelona, Spain [email\xa0protected]', 'institution_ids': []}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 8, 'citation_normalized_percentile': {'value': 0.641921, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 80, 'max': 81}, 'biblio': {'volume': '25', 'issue': '1', 'first_page': '91', 'last_page': '92'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10414', 'display_name': 'Endocannabinoid System and Its Effects on Health', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10414', 'display_name': 'Endocannabinoid System and Its Effects on Health', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11635', 'display_name': 'Management of Poisoning and Toxic Exposures', 'score': 0.9961, 'subfield': {'id': 'https://openalex.org/subfields/2711', 'display_name': 'Emergency Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia Research and Treatment', 'score': 0.9951, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/neuroprotection', 'display_name': 'Neuroprotection', 'score': 0.536184}, {'id': 'https://openalex.org/keywords/extracorporeal-treatments', 'display_name': 'Extracorporeal Treatments', 'score': 0.528254}, {'id': 'https://openalex.org/keywords/cannabis-use', 'display_name': 'Cannabis Use', 'score': 0.520421}, {'id': 'https://openalex.org/keywords/neuroanatomical-abnormalities', 'display_name': 'Neuroanatomical Abnormalities', 'score': 0.509066}, {'id': 'https://openalex.org/keywords/medical-marijuana', 'display_name': 'Medical Marijuana', 'score': 0.503104}], 'concepts': [{'id': 'https://openalex.org/C2777056318', 'wikidata': 'https://www.wikidata.org/wiki/Q79817', 'display_name': 'Cannabis', 'level': 2, 'score': 0.56628746}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.45915356}, {'id': 'https://openalex.org/C2779473830', 'wikidata': 'https://www.wikidata.org/wiki/Q1540899', 'display_name': 'MEDLINE', 'level': 2, 'score': 0.41346353}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.38468143}, {'id': 'https://openalex.org/C15744967', 'wikidata': 'https://www.wikidata.org/wiki/Q9418', 'display_name': 'Psychology', 'level': 0, 'score': 0.3530759}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.080991894}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D001480', 'descriptor_name': 'Basal Ganglia Diseases', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': True}, {'descriptor_ui': 'D002188', 'descriptor_name': 'Cannabis', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001480', 'descriptor_name': 'Basal Ganglia Diseases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002188', 'descriptor_name': 'Cannabis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/01.jcp.0000150235.37737.02', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S76849566', 'display_name': 'Journal of Clinical Psychopharmacology', 'issn_l': '0271-0749', 'issn': ['0271-0749', '1533-712X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15643106', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 9, 'referenced_works': ['https://openalex.org/W1603590524', 'https://openalex.org/W1981252279', 'https://openalex.org/W1985949232', 'https://openalex.org/W2045605718', 'https://openalex.org/W2072094115', 'https://openalex.org/W2089615886', 'https://openalex.org/W2098644261', 'https://openalex.org/W2099241624', 'https://openalex.org/W2173542745'], 'related_works': ['https://openalex.org/W904282840', 'https://openalex.org/W4389568370', 'https://openalex.org/W3193394349', 'https://openalex.org/W3083951532', 'https://openalex.org/W3032375762', 'https://openalex.org/W3031052312', 'https://openalex.org/W2748952813', 'https://openalex.org/W2586801360', 'https://openalex.org/W2080531066', 'https://openalex.org/W1995515455'], 'abstract_inverted_index': {'Rejón': [0], 'Altable,': [1], 'Carlos': [2], 'MD;': [3, 7], 'Rodríguez': [4], 'Urrutia,': [5], 'Amanda': [6], 'Carrión': [8], 'Martínez,': [9], 'Ma.': [10], 'Isabel': [11], 'MD': [12], 'Author': [13], 'Information': [14]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2410206662', 'counts_by_year': [{'year': 2016, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-09-01T05:59:53.106452', 'created_date': '2016-06-24'}